ASPEN PHARMACARE H. NEW revenue for the last year amounted to 2.28 B EUR, the most of which — 720.58 M EUR — came from its highest performing source at the moment, Manufacturing, the year earlier bringing 547.90 M EUR. The greatest contribution to the revenue figure was made by Europe & Commonwealth of Independent States — last year it brought ASPEN PHARMACARE H. NEW 897.31 M EUR, and the year before that — 709.88 M EUR.